Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
It was approved by US FDA in 2011 to treat castration-resistant prostate cancer
in both cancer cells and normal cells
30-tris(propan-2-yl)-1
is a potent and selective protein kinase C (PKC) inhibitor
Eluxadoline Catalog No.:M8654-10 It was approved by USEluxadoline is an orally active drug approved for the treatment of diarrhea and abdominal pain in individuals with diarrhea predominant irritable bowel syndrome (IBS D). Eluxadoline is a and opioid receptor agonist and opioid receptor antagonist that acts locally in the enteric nervous system, possibly decreasing adverse effects on the central nervous system. This product is discontinued (DEA Schedule IV). Product information CAS Number: 864821 90 9
US$ 2649.01
US$ 72500.00